9915 ISTH Podcast 7

If Other, please specify:

2. What is your role in the care of individuals with hemophilia? Select all that apply

Physician involved in direct patient care (management and monitoring of bleeding risk)
Investigator in clinical trials of patients with hemophilia
Perform assays/assessments in a specialized coagulation laboratory
Physical, occupational, and/or mental health therapy
Basic research related to hemophilia, but not related to patient care
Patient education
Other (please specify) Please enter an 'other' value for this selection.

5. Please rate your KNOWLEDGE of discrepancies between factor activity endpoints measured with different assays in hemophilia gene therapy clinical trials: *This question is required.

Space Cell	0 - Not Relevant	1 - Lowest	2 - Low	3 - Moderate	4 - High	5 - Highest
Before the Activity	Before the Activity : 0 - Not Relevant	Before the Activity : 1 - Lowest	Before the Activity : 2 - Low	Before the Activity : 3 - Moderate	Before the Activity : 4 - High	Before the Activity : 5 - Highest
After the Activity	After the Activity : 0 - Not Relevant	After the Activity : 1 - Lowest	After the Activity : 2 - Low	After the Activity : 3 - Moderate	After the Activity : 4 - High	After the Activity : 5 - Highest

6. Please rate your ABILITY to critically evaluate factor activity results reported from hemophilia gene therapy clinical trials: *This question is required.

Space Cell	0 - Not Relevant	1 - Lowest	2 - Low	3 - Moderate	4 - High	5 - Highest
Before the Activity	Before the Activity : 0 - Not Relevant	Before the Activity : 1 - Lowest	Before the Activity : 2 - Low	Before the Activity : 3 - Moderate	Before the Activity : 4 - High	Before the Activity : 5 - Highest
After the Activity	After the Activity : 0 - Not Relevant	After the Activity : 1 - Lowest	After the Activity : 2 - Low	After the Activity : 3 - Moderate	After the Activity : 4 - High	After the Activity : 5 - Highest

7. Do you intend to make changes or apply new knowledge to your practice as a result of this activity? *This question is required.

Please check off what you intend to do differently or incorporate into your clinical management of patients as a result of this educational activity.

Review the literature on AAV gene therapy for hemophilia
Improve ability to interpret factor activity levels reported in hemophilia gene therapy clinical trials
Confirm the factor assays currently in use for patients with hemophilia within your clinical practice environment
Access literature on clinical trials of gene therapy for patients with hemophilia
Discuss gene therapy in the context of other therapies for hemophilia with peers/colleagues
Identify patients who may be eligible for current and emerging hemophilia gene therapy clinical trials
Stay up-to-date with new developments of gene therapy for patients with hemophilia
Other, please specify Please enter an 'other' value for this selection.

8. Please provide a specific way in which this activity will impact your patient care

9. Was the format of this educational activity appropriate for the content presented? *This question is required.

10. Did this educational activity meet your learning needs? *This question is required.

11. How might the format of this activity be improved?

12. What educational topics would you like to see addressed in future activities?

13. Was this activity scientifically sound and free of commercial bias or influence? *This question is required.

14. If "No" please explain:

9915 ISTH Podcast 7

Evaluation